Advertisement

Table of Contents

February 28, 2019; 133 (9)

BLOOD COMMENTARIES

PLENARY PAPER

BLOOD SPOTLIGHT

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

LYMPHOID NEOPLASIA

  • <em>CCND2</em> and <em>CCND3</em> hijack immunoglobulin light-chain enhancers in cyclin D1<sup>−</sup> mantle cell lymphoma
    CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 mantle cell lymphoma
    David Martín-Garcia, Alba Navarro, Rafael Valdés-Mas, Guillem Clot, Jesús Gutiérrez-Abril, Miriam Prieto, Inmaculada Ribera-Cortada, Renata Woroniecka, Grzegorz Rymkiewicz, Susanne Bens, Laurence de Leval, Andreas Rosenwald, Judith A. Ferry, Eric D. Hsi, Kai Fu, Jan Delabie, Dennis Weisenburger, Daphne de Jong, Fina Climent, Sheila J. O’Connor, Steven H. Swerdlow, David Torrents, Sergi Beltran, Blanca Espinet, Blanca González-Farré, Luis Veloza, Dolors Costa, Estella Matutes, Reiner Siebert, German Ott, Leticia Quintanilla-Martinez, Elaine S. Jaffe, Carlos López-Otín, Itziar Salaverria, Xose S. Puente, Elias Campo and Sílvia Beà
  • Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
    Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
    Dennis Dobrovolsky, Eric S. Wang, Sara Morrow, Catharine Leahy, Tyler Faust, Radosław P. Nowak, Katherine A. Donovan, Guang Yang, Zhengnian Li, Eric S. Fischer, Steven P. Treon, David M. Weinstock and Nathanael S. Gray
  • The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
    The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
    Rabea Wagener, Julian Seufert, Francesco Raimondi, Susanne Bens, Kortine Kleinheinz, Inga Nagel, Janine Altmüller, Holger Thiele, Daniel Hübschmann, Christian W. Kohler, Peter Nürnberg, Rex Au-Yeung, Birgit Burkhardt, Heike Horn, Lorenzo Leoncini, Elaine S. Jaffe, German Ott, Grzegorz Rymkiewicz, Matthias Schlesner, Robert B. Russell, Wolfram Klapper and Reiner Siebert

THROMBOSIS AND HEMOSTASIS

  • A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
    A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
    Paul S. de Vries, Maria Sabater-Lleal, Jennifer E. Huffman, Jonathan Marten, Ci Song, Nathan Pankratz, Traci M. Bartz, Hugoline G. de Haan, Graciela E. Delgado, John D. Eicher, Angel Martinez-Perez, Cavin K. Ward-Caviness, Jennifer A. Brody, Ming-Huei Chen, Moniek P. M. de Maat, Mattias Frånberg, Dipender Gill, Marcus E. Kleber, Fernando Rivadeneira, José Manuel Soria, Weihong Tang, Geoffrey H. Tofler, André G. Uitterlinden, Astrid van Hylckama Vlieg, Sudha Seshadri, Eric Boerwinkle, Neil M. Davies, Anne-Katrin Giese, M. Kamran Ikram, Steven J. Kittner, Barbara McKnight, Bruce M. Psaty, Alex P. Reiner, Muralidharan Sargurupremraj, Kent D. Taylor, INVENT Consortium, MEGASTROKE Consortium of the International Stroke Genetics Consortium, Myriam Fornage, Anders Hamsten, Winfried März, Frits R. Rosendaal, Juan Carlos Souto, Abbas Dehghan, Andrew D. Johnson, Alanna C. Morrison, Christopher J. O'Donnell and Nicholas L. Smith
  • Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT
    Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT
    Krystin Krauel, Patricia Preuße, Theodore E. Warkentin, Catja Trabhardt, Sven Brandt, Inga Jensch, Martin Mandelkow, Elke Hammer, Sven Hammerschmidt and Andreas Greinacher

LETTERS TO BLOOD

BLOOD WORK